Steven D. Nathan, MD

Medical Director, Lung Transplant Program
Medical Director, Advanced Lung Disease Program
Inova Fairfax Hospital
Falls Church, Virginia

Steven D. Nathan, MD, is the Medical Director of the Advanced Lung Disease Program and Medical Director of the Lung Transplant Program at Inova Fairfax Hospital in Falls Church, Virginia. He is also an Affiliate Professor of Biomedical Sciences at George Mason University. Dr. Nathan received his medical degree at the University of the Witwatersrand Medical School in Johannesburg, South Africa. He completed his internship in Internal Medicine and General Surgery at the Johannesburg Hospital. Dr. Nathan performed his Internal Medicine residency at Long Island Jewish Hospital in New York City, and completed his fellowships in Pulmonary Medicine, Critical Care, and Lung Transplantation at Cedars-Sinai Medical Center in Los Angeles, California. He is board certified in Internal Medicine, Pulmonary Diseases, and Critical Care Medicine.

Dr. Nathan has been widely published in a number of peer–reviewed journals and publications, such as Chest and the Journal of Heart and Transplantation. He has since been awarded the Jubilee Award for his achievements from the University of the Witwatersrand. He also sits on the editorial board for Progress in Transplantation. Dr. Nathan is a member of several professional medical associations, including the American Thoracic Society and the International Society for Heart and Lung Transplantation, and is a member of the American College of Chest Physicians Network Interstitial Lung Disease Steering Committee.

Disclosure Statement

It is the policy of The France Foundation to ensure balance, independence, objectivity, and scientific rigor in all its sponsored educational activities. All faculty involved in the development of this activity have disclosed any significant financial interest or other relationship with manufacturer(s) of any commercial product(s)/device(s) and/or provider(s) of commercial services included in this educational activity. The intent of this disclosure is not to prevent a faculty member with a relevant financial or other relationship from participating in the activity, but rather to provide participants with information on which they can base their own judgments. The France Foundation has identified and resolved any and all faculty conflicts of interest prior to the release of this activity.

Steven D. Nathan, MD, has served as a consultant for and received honoraria from Actelion, Gilead, and United Therapeutics. He has received grant and research support from Actelion, Gilead, InterMune, and United Therapeutics.

Disclaimer
The opinions, recommendations, and guidelines expressed herein are those of the PILOT™ Steering Committee and other contributing faculty, and not necessarily those of The France Foundation or InterMune, who assume no responsibility or liability for the material that appears herein.